Headquartered in Delaware USA, Sepax Technologies, Inc. is a privately held company founded in November 2002. Sepax focuses on customers’ needs and provides solutions to customer’s challenges in chromatographic separation science. Sepax develops and manufactures HPLC consumables, bulk media, and equipment for chemical and biological separations in liquid chromatography. Sepax is a fast growing technology company and has emerged as a leader in the biological separation industry. Sepax has been developing wide range of intellectual properties in the areas of particle synthesis, surface modification, LC column packing, bulk media production, and purification process development. Sepax Quality Management System is ISO 9001:2008 certified.
At Sepax, we believe that we create value through serving customers' needs and solving customers’ challenges in chromatography separation and purification industry. Through innovative technologies and solution based approaches, we deliver products and services to build lasting relationships with our customers and achieve leadership position in the industry.
Sepax Technologies, Inc. is located in Delaware Technology Park with facilities of 15,000 ft2 dedicated to the development and production of separation resins, LC columns and related consumables. It is also the marketing and sales center servicing US and the global markets.
Sepax Technologies, Inc. focuses on three business areas: 1) bioanalytical solutions, 2) solution based process purification and 3) medical diagnostics.
In bioanalytical area, we provide comprehensive LC column products and services to meet the needs of each market fragment of the biomolecules separation and analysis.
For process chromatography, we provide solutions to customers’ needs for various scales of the purification, including process development, bulk media and equipment.
Our innovative technologies deliver unique products for medical diagnostics, such as GlyHb, a high resolution product for diagnosis of diabetes.